article thumbnail

Avalon Ventures: Startups Get Milestone Payments, New Company Launched With GSK

socalTECH

San Diego-based Avalon Ventures , and COI Pharmaceuticals , the company established by Avalon to help form new biotech companies, said today that the first two companies that it has formed with GlaxoSmithKline have met their first milestones, and that it has spun up a new company with GSK as part of their collaboration.

Avalon 113
article thumbnail

Avalon Ventures, GlaxoSmithKline Team On Two New Startups

socalTECH

San Diego-based venture capital investor Avalon Ventures and biopharmaceuticals firm GlaxoSmithKline said Monday that the two have teamed up to fund and launch up to 10, early stage life science companies. According to Avalon Ventures and GSK, they will provide up to $495M to fund those ten new companies.

Avalon 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Avalon Ventures Launches Trio Of Life Science Startups

socalTECH

San Diego-based Avalon Ventures said this morning that it has launched and funded three, new companies as part of its deal with GSK. Avalon Venturs said that Adrenergics , CadheRx Therapeutics , and Calporta Therapeutics have all received $10M in Series A funding, and will receive R&D support from Avalon Ventures and GSK.

Avalon 100
article thumbnail

Calporta, Started by Avalon Ventures-GSK, Is Acquired by Merck

Xconomy

Another of the biopharma startups created as part of a collaboration between San Diego investment firm Avalon Ventures and GlaxoSmithKline has been acquired—but not by GSK. Debuting in COI (which stands for “community of innovation”). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Avalon 73
article thumbnail

Avalon Ventures Raises $201.6M As Part Of $250M Venture Fund

socalTECH

In what is a rarity nowadays for a Southern California venture capital fund, San Diego- and Cambridge-based venture capital firm Avalon Ventures has just closed on $201.6M in commitments for a $250M fund, Avalon Ventures X. The funding was disclosed via a regulatory filing Thursday. READ MORE>>.

Avalon 184
article thumbnail

Janux Therapeutics Prices IPO, Hits Nasdaq Today

socalTECH

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX.

Pricing 113
article thumbnail

Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup

Xconomy

[ Note: The headline has been corrected to better describe the company’s type of funding. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40